Activation of FGF signaling mediates proliferative and osteogenic differences between neural crest derived frontal and mesoderm parietal derived bone

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Li, Shuli ^a   Quarto, Natalina ^a,b   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1 PROTEIN, MOUSE; RECOMBINANT PROTEIN;

ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL INTERACTION; CELL LEVEL; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; FRONTAL BONE; MESODERM; MOUSE; NEURAL CREST CELL; NEWBORN; NONHUMAN; OSTEOBLAST; PERINATAL PERIOD; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SKULL; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; IMMUNOBLOTTING; METABOLISM; NEURAL CREST; RNA INTERFERENCE;

MAMMALIA;

ANIMALS; ANIMALS, NEWBORN; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FIBROBLAST GROWTH FACTOR 2; FRONTAL BONE; IMMUNOBLOTTING; MESODERM; MICE; NEURAL CREST; OSTEOBLASTS; OSTEOGENESIS; PARIETAL BONE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECOMBINANT PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 78649529237     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014033     Document Type: Article

References (37)

1. Morriss-Kay GM (2001) Derivation of the mammalian skull vault. J Anat 199(Pt 1-2): 143-151.
2. Chai Y, Jiang X, Ito Y, Bringas P, Jr., Han J, et al. (2000) Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 127(8): 1671-1679.
3. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM (2002) Tissue origins and interactions in the mammalian skull vault. Dev Biol 241(1): 106-116.
4. LaBonne C, Bronner-Fraser M (1999) Molecular mechanisms of neural crest formation. Annu Rev Cell Dev Biol 15: 81-112.
5. Anderson DJ (2000) Genes, lineages and the neural crest: a speculative review. Philos Trans R Soc Lond B Biol Sci 355(1399): 953-964.
6. Trainor P, Krumlauf R (2002) Development. Riding the crest of the Wnt signaling wave. Science 297(5582): 781-783.
7. Couly G, Grapin-Botton A, Coltey P, Le Douarin NM (1996) The regeneration of the cephalic neural crest, a problem revisited: the regenerating cells originate from the contralateral or from the anterior and posterior neural fold. Development 122(11): 3393-3407.
8. Kontges G, Lumsden A (1996) Rhombencephalic neural crest segmentation is preserved throughout craniofacial ontogeny. Development 122(10): 3229-3242.
9. Le Douarin NM, Calloni GW, Dupin E (2008) The stem cells of the neural crest. Cell Cycle 7(8): 1013-1019.
10. Karsenty G (2001) Minireview: transcriptional control of osteoblast differentiation. Endocrinology 142(7): 2731-2733.
11. Karsenty G, Wagner EF (2002) Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2(4): 389-406.
12. Karsenty G (2008) Transcriptional control of skeletogenesis. Annu Rev Genomics Hum Genet 9: 183-196.
13. Muenke M, Schell U (1995) Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 11(8): 308-313.
14. Naski MC, Ornitz DM (1998) FGF signaling in skeletal development. Front Biosci 3: d781-794.
15. Ornitz DM, Itoh N (2001) Fibroblast growth factors. Genome Biol 2(3): REVIEWS3005.
16. Marie PJ (2003) Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 316: 23-32.
17. Mansukhani A, Bellosta P, Sahni M, Basilico C (2000) Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol 149(6): 1297-1308.
18. Cowan CM, Quarto N, Warren SM, Salim A, Longaker MT (2003) Age-related changes in the biomolecular mechanisms of calvarial osteoblast biology affect fibroblast growth factor-2 signaling and osteogenesis. J Biol Chem 278(34): 32005-32013.
19. Fakhry A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, et al. (2005) Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stagedependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 36(2): 254-266.
20. Quarto N, Longaker MT (2006) FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 12(6): 1405-1418.
21. Dailey L, Ambrosetti D, Mansukhani A, Basilico C (2005) Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev 16(2): 233-247.
22. Jackson RA, Nurcombe V, Cool SM (2006) Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 379: 79-91.
23. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, et al. (2008) Regulation of osteogenic differentiation during skeletal development. Front Biosci 13: 2001-2021.
24. Chaudhary LR, Avioli LV (1997) Activation of extracellular signal-regulated kinases 1 and 2 (ERK1 and ERK2) by FGF-2 and PDGF-BB in normal human osteoblastic and bone marrow stromal cells: differences in mobility and in-gel renaturation of ERK1 in human, rat, and mouse osteoblastic cells. Biochem Biophys Res Commun 238(1): 134-139.
25. Kim HJ, Kim JH, Bae SC, Choi JY, Kim HJ, et al. (2003) The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J Biol Chem 278(1): 319-326.
26. Chaudhary LR, Hofmeister AM, Hruska KA (2004) Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 34(3): 402-411.
27. Quarto N, Wan DC, Kwan MD, Panetta NJ, Li S, et al. (2009) Origin Matters: Differences in Embryonic Tissue Origin and Wnt Signaling Determine the Osteogenic Potential and Healing Capacity of Frontal and Parietal Calvarial Bones. J Bone Miner Res 25(7): 1680-1694.
28. Quarto N, Behr B, Li S, Longaker MT (2009) Differential FGF ligands and FGF receptors expression pattern in frontal and parietal calvarial bones. Cells Tissues Organs 190(3): 158-169.
29. Quarto N, Wan DC, Longaker MT (2008) Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs). Bone 42(6): 1040-1052.
30. Debiais F, Lefevre G, Lemonnier J, Le Mee S, Lasmoles F, et al. (2004) Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway. Exp Cell Res 297(1): 235-246.
31. Ornitz DM, Marie PJ (2002) FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16(12): 1446-1465.
32. Li S, Quarto N, Longaker MT (2007) Dura mater-derived FGF-2 mediates mitogenic signaling in calvarial osteoblasts. Am J Physiol Cell Physiol 293(6): C1834-1842.
33. Yang D, Guo J, Divieti P, Bringhurst FR (2006) Parathyroid hormone activates PKC-delta and regulates osteoblastic differentiation via a PLC-independent pathway. Bone 38(4): 485-496.
34. Sandeep Robert Datta SR, et al. (1999) Cellular survival: a play in three Akts. Genes & Development 13: 2905-2927.
35. Chaudhary LR, Hruska KA (2001) The cell survival signal Akt is differentially activated by PDGF-BB, EGF, and FGF-2 in osteoblastic cells. J Cell Biochem 81(2): 304-311.
36. Paling NR, Wheadon H, Bone HK, Welham MJ (2004) Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J Biol Chem 279(46): 48063-48070.
37. Trentin A, Glavieux-Pardanaud C, Le Douarin NM, Dupin E (2004) Selfrenewal capacity is a widespread property of various types of neural crest precursor cells. Proc Natl Acad Sci U S A 101(13): 4495-4500.